Vahlensieck W, Wegner G
Scand J Urol Nephrol Suppl. 1980;55:147-9.
A preliminary report is presented of prospective, randomized study with continuous and intermittent oral Estracyt treatment in patients with prostatic carcinoma. It seems that the therapeutic effect of intermittent treatment is as favorable as continuous therapy. Side effects and costs are lower with intermittent therapy.
本文呈现了一项关于前列腺癌患者连续及间歇性口服依斯特拉昔治疗的前瞻性随机研究的初步报告。间歇性治疗的疗效似乎与连续治疗一样良好。间歇性治疗的副作用和成本更低。